Embla Medical hf.
OSSFFOTCHealthcare● Active
$5.11
+$0.96(+23.13%)
Market Cap$2.2B
P/E Ratio—
52W High$5.325
52W Low$4.15
Embla Medical hf. (OSSFF) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · OSSFF · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.96B | $0.85B | $0.79B | $0.72B | $0.72B |
| Cost of Revenue | $0.40B | $0.32B | $0.30B | $0.28B | $0.26B |
| Gross Profit | $0.56B | $0.53B | $0.49B | $0.44B | $0.46B |
| Gross Margin %(computed) | 58.18% | 62.55% | 61.80% | 61.19% | 63.37% |
| Operating Expenses | |||||
| R&D Expenses | $0.04B | $0.04B | $0.04B | $0.03B | $0.03B |
| G&A Expenses | $0.00B | $0.07B | $0.07B | $0.07B | $0.07B |
| Total Operating Expenses | $0.43B | $0.42B | $0.40B | $0.37B | $0.36B |
| Operating Income | $0.13B | $0.11B | $0.09B | $0.06B | $0.10B |
| Operating Margin %(computed) | 13.43% | 13.19% | 11.38% | 9.02% | 13.54% |
| Interest Income | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.02B | $0.02B | $0.02B | $0.01B | $0.01B |
| Income Before Tax | $0.11B | $0.09B | $0.08B | $0.06B | $0.09B |
| Income Tax Expense | $0.03B | $0.02B | $0.02B | $0.01B | $0.02B |
| Net Income | $0.09B | $0.07B | $0.06B | $0.04B | $0.06B |
| Net Margin %(computed) | 8.97% | 7.99% | 7.43% | 5.92% | 8.90% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $0.20 | $0.16 | $0.14 | $0.10 | $0.15 |
| Wtd Avg Shares | 0.43B | 0.43B | 0.42B | 0.42B | 0.42B |
| EBITDA | $0.19B | $0.17B | $0.15B | $0.12B | $0.14B |
| EBITDA Margin %(computed) | 19.71% | 19.86% | 18.60% | 16.70% | 20.14% |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · B
Explore more Embla Medical hf. data
About Embla Medical hf. (OSSFF) Income Statement
Embla Medical hf. (OSSFF) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, OSSFF reported revenue of $0.96B, gross profit of $0.56B (gross margin 58.18%), and net income of $0.09B — a net profit margin of 8.97%.
Frequently asked questions
OSSFF · 4 questionsEmbla Medical hf. (OSSFF) reported revenue of $0.96B for 2025, up 12.7% year-over-year.
OSSFF revenueOSSFF salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09